CD4 T Cells Reactive to Hybrid Insulin Peptides Are Indicators of Disease Activity in the NOD Mouse

Rocky L. Baker(University of Colorado Denver), Braxton L. Jamison(University of Colorado Denver), Timothy A. Wiles(University of Colorado Denver), Robin S. Lindsay(National Jewish Health), Gene Barbour(University of Colorado Denver), Brenda Bradley(University of Colorado Denver), Thomas Delong(University of Colorado Denver), Rachel S. Friedman(National Jewish Health), Maki Nakayama(University of Colorado Denver), Kathryn Haskins(University of Colorado Denver)
Diabetes
July 5, 2018
Cited by 68Open Access
Full Text

Abstract

We recently established that hybrid insulin peptides (HIPs), formed in islet β-cells by fusion of insulin C-peptide fragments to peptides of chromogranin A or islet amyloid polypeptide, are ligands for diabetogenic CD4 T-cell clones. The goal of this study was to investigate whether HIP-reactive T cells were indicative of ongoing autoimmunity. MHC class II tetramers were used to investigate the presence, phenotype, and function of HIP-reactive and insulin-reactive T cells in NOD mice. Insulin-reactive T cells encounter their antigen early in disease, but they express FoxP3 and therefore may contribute to immune regulation. In contrast, HIP-reactive T cells are proinflammatory and highly diabetogenic in an adoptive transfer model. Because the frequency of antigen-experienced HIP-reactive T cells increases over progression of disease, they may serve as biomarkers of autoimmune diabetes.


Related Papers

No related papers found

Powered by citation graph analysis